06:20:29 EDT Sun 07 Jun 2020
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save

Z:ABBV - ABBVIE INC - http://www.abbvie.com06:20:29 EDT
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
ABBV - Z0.193.65·94.040.893.85+0.810.99,630.1906,61078,65193.50  95.54  92.8197.86  62.5519:59:5606:0015 min RT 2¢

Recent Trades - Last 10 of 78651
Time ETExPriceChangeVolume
19:59:56Z93.970.9310
19:59:56Z94.041.0010
19:59:32Z93.900.8610
19:56:45Z93.900.86100
19:56:38Z93.910.87100
19:55:59Z93.910.87100
19:55:29Z93.900.8643
19:54:35Z93.900.8610
19:54:26Z94.030.992
19:54:26Z94.041.00198

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent BulletinsNews ReleasesIn The NewsOther
Date ETSymbolTypeHeadline
2020-06-06 08:30U:ABBVNews ReleaseAbbVie Presents Data Showing RINVOQ ™ (upadacitinib) Meets Primary and Key Secondary Endpoints in Phase 3 Head-to-Head Study Versus ORENCIA (abatacept) in Rheumatoid Arthritis Patients
2020-06-05 06:00U:ABBVNews ReleaseAbbVie, Harbour BioMed, Utrecht University and Erasmus Medical Center Announce Collaboration to Develop Monoclonal Antibody Therapy to Prevent and Treat COVID-19
2020-06-04 08:30U:ABBVNews ReleaseNew Long-term Data from RINVOQ ™ (upadacitinib, 15 mg) Phase 3 Studies in Rheumatoid Arthritis Presented at 2020 Annual European E-Congress of Rheumatology (EULAR)
2020-06-04 07:00U:ABBVNews ReleaseDr. Keshav K. Singh Joins Allergan Aesthetics Science Of Aging(SM) Faculty
2020-06-03 08:00U:ABBVNews ReleaseAbbVie to Present at the Virtual Goldman Sachs 41st Annual Global Healthcare Conference
2020-06-01 11:40U:ABBVNews ReleaseAbbVie Submits Regulatory Applications to FDA and EMA for RINVOQ ™ (upadacitinib) for the Treatment of Adults with Active Psoriatic Arthritis
2020-06-01 08:30U:ABBVNews ReleaseAllergan Aesthetics Launches Dedicated Multi-Channel Campaign To Contact Patients Who May Not Be Aware Of The BIOCELL ® Recall And To Improve Tracking Information For U.S. Breast Implant Patients
2020-06-01 01:00U:ABBVNews ReleaseAbbVie and Jacobio Announce Strategic Collaboration to Advance SHP2 Inhibitors
2020-05-29 16:14U:ABBVNews ReleaseFDA Approves the First Oral Medication for the Management of Heavy Menstrual Bleeding Due to Uterine Fibroids in Pre-menopausal Women
2020-05-27 08:30U:ABBVNews ReleaseAbbVie Presents New Data at the European E-Congress of Rheumatology (EULAR) 2020 Showcasing Depth of its Rheumatology Portfolio
2020-05-15 08:30U:ABBVNews ReleaseAbbVie Data at EHA Annual Congress Highlight Depth and Breadth of Transformative Blood Cancer Portfolio
2020-05-14 08:00U:ABBVNews ReleaseAbbVie to Present at the UBS Virtual Healthcare Conference
2020-05-13 08:00U:ABBVNews ReleaseAbbVie Announces Final Results of Exchange Offers for Allergan Notes